Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand?

Stem Cells
Elodie GouadonMichel Pucéat

Abstract

Heart failure is still a major cause of hospitalization and mortality in developed countries. Many clinical trials have tested the use of multipotent stem cells as a cardiac regenerative medicine. The benefit for the patients of this therapeutic intervention has remained limited. Herein, we review the pluripotent stem cells as a cell source for cardiac regeneration. We more specifically address the various challenges of this cell therapy approach. We question the cell delivery systems, the immune tolerance of allogenic cells, the potential proarrhythmic effects, various drug mediated interventions to facilitate cell grafting and, finally, we describe the pathological conditions that may benefit from such an innovative approach. As members of a transatlantic consortium of excellence of basic science researchers and clinicians, we propose some guidelines to be applied to cell types and modes of delivery in order to translate pluripotent stem cell cardiac derivatives into safe and effective clinical trials.

References

Nov 6, 1998·Science·J A ThomsonJ M Jones
Oct 26, 1999·Cardiovascular Research·J M Pinto, P A Boyden
Oct 28, 2003·The Journal of Physiology·Jürgen F HeubachUrsula Ravens
Feb 10, 2004·The Journal of Physiology·Virginijus ValiunasIra S Cohen
May 4, 2005·The Journal of Thoracic and Cardiovascular Surgery·Nicolas BorensteinEmmanuel Le Bret
Jun 24, 2005·The New England Journal of Medicine·Bart KeymeulenLucienne Chatenoud
Nov 16, 2005·Journal of the American College of Cardiology·Saskia L M A BeeresMartin J Schalij
Apr 4, 2006·Nature Medicine·Wolfram-Hubertus ZimmermannThomas Eschenhagen
Oct 25, 2006·Circulation·Norbert F VoelkelUNKNOWN National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure
Jul 31, 2007·Nature Medicine·Elisabeth M ZeisbergRaghu Kalluri
Sep 14, 2007·Circulation·Yalin YildirimWolfram-Hubertus Zimmermann
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Rutger-Jan SwijnenburgJoseph C Wu
Oct 22, 2008·Cell Stem Cell·Jeremy Micah CrookAlan Colman
Nov 26, 2008·Circulation Research·Massimiliano GnecchiVictor J Dzau
Jan 1, 1974·Annual Review of Physiology·J R Neely, H E Morgan
Jan 12, 2010·Developmental Cell·Sally L Dunwoodie
Apr 24, 2010·The Journal of Thoracic and Cardiovascular Surgery·Virginie LambertJean-François Renaud
Sep 30, 2010·The Journal of Experimental Medicine·Natalia Tapia, Hans R Schöler
Mar 29, 2011·Veterinary Pathology·M M SwindleK S Frazier
May 11, 2011·Circulation·Gilles W De Keulenaer, Dirk L Brutsaert
Jun 29, 2011·Circulation·Mariell JessupUNKNOWN Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) Investigators
Sep 8, 2011·Journal of Cellular and Molecular Medicine·Damelys CalderonLucienne Chatenoud
Sep 17, 2011·Circulation Research·Keisuke OkitaShinya Yamanaka
Oct 21, 2011·Tissue Engineering. Part a·Brian A AguadoSarah C Heilshorn
Apr 19, 2012·Circulation. Arrhythmia and Electrophysiology·Stephan Rohr

❮ Previous
Next ❯

Citations

Feb 26, 2016·Nature Reviews. Molecular Cell Biology·Alan Trounson, Natalie D DeWitt
Feb 24, 2016·Biochemical Pharmacology·Ramin KhanabdaliShiang Y Lim
May 26, 2017·Journal of Cellular Biochemistry·Nasser Hashemi GoradelHamed Mirzaei
Jun 10, 2017·Circulation Research·Yoshinori Yoshida, Shinya Yamanaka
Jul 26, 2019·Journal of the American Heart Association·Peter V JohnstonGary Gerstenblith
Jul 30, 2020·Stem Cells Translational Medicine·Qiang LiHuang-Tian Yang
Mar 27, 2018·Chinese Medical Journal·Feng WangJian-Yan Wen
Dec 14, 2016·Journal of Materials Chemistry. B, Materials for Biology and Medicine·J K PonniahJ G Jacot
Jan 6, 2018·Npj Regenerative Medicine·Susanne SattlerSian E Harding
Oct 31, 2018·International Journal of Molecular Sciences·Brian X WangCesare M N Terracciano
Feb 8, 2019·Tissue Engineering. Part a·Alicia C B AllenJanet Zoldan
Apr 25, 2020·Frontiers in Immunology·Marcus J WagnerSadia Mohsin
Mar 23, 2018·ACS Applied Nano Materials·Jeanne E LemasterJesse V Jokerst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Related Papers

Heart, Lung & Circulation
Thi Yen Loan LeJames Jh Chong
Stem Cell Reviews
M William LenschThorsten M Schlaeger
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie
Elena CambriaMaximilian Y Emmert
© 2021 Meta ULC. All rights reserved